drugset / Trial / NCT03475121
Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This protocol provides guidelines for the management of non-metastatic unilateral retinoblastoma and introduces an innovative adjuvant therapy for higher risk patients based upon the results of the Grupo de America Latina de Oncologia Pediatrica (GALOP) I study. Conservative therapy will be not protocolized.
Timeline
- Start
- 2018-01-01
- Primary completion
- 2023-01-31
- Completion
- 2025-03-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Idarubicin | Small molecule | — | — |
| Subject | Topotecan | Small molecule | — | Intrathecal |
| Subject | Vincristine | Small molecule | — | — |